News
Duke Street Bio News
Duke Street Bio Announces Appointment of Chief Medical Officer
Duke Street Bio has strengthed its executive leadership team with the appointment of Dónal Landers, MB BCh BAO, MBA, DPM, FFPM as Chief Medical Officer.
Next Gen PARP1 & PARP7 inhibitor programmes
Duke Street Bio – DDR & IO biotech emerges from stealth mode to discuss its next generation PARP1 and PARP7 inhibitor programmes.
Delivering life-saving cancer treatments to improve patient outcomes.